Increasing Demand for Pharmaceutical Drugs to Drive the North American Pharmaceutical Excipient Market

The North American pharmaceutical excipient market is estimated to grow at a CAGR of 7.9% during the forecast period. The increasing demand for pharmaceutical and biopharmaceutical drugs in the region significantly drives the growth of the market. Along with this, pharmaceutical patented drug approval of biosimilar is also expected to expand the market during the forecast period. 

Browse the full report description North American Pharmaceutical Excipient Market Size, Share & Trends Analysis Report, By Product (Solubilizer & Surfactants/Emulsifiers, Polyols, Carbohydrates, and Specialty Excipients), By Formulation (Oral Formulation, Topical Formulations, Parenteral Formulations, and Other Formulations), and Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/north-american-pharmaceutical-excipient-market

The US FDA started approving biosimilars in March 2010. The cost of biosimilars is 20-40% less in the US, which provides an ample opportunity for the growth of the biosimilar industry and hence drives the growth of their excipients.

There is a substantial overall economic impact of the biopharmaceutical industry on the US economy. According to the International Trade Administration, the industry accounted for more than $1.3 trillion in economic output, representing 4% of total US output in 2015. The economic impact includes around $558 billion in revenue from the biopharmaceutical industry. 

An exceptional growth for biopharmaceutical innovation has been noticed in 2015. The US FDA approved 56 new medicines, that included 45 new medicines approved by the Center for Drug Evaluation and Research (CDER)—the highest number of approvals in almost two decades. The US biopharmaceutical research sector has been involved in the development of new medicines, and it continues to drive biopharmaceutical innovation for patients in the near future.

Market Coverage

• Market number available for – 2018-2025
• Base year- 2018
• Forecast period- 2019-2025
• Segment Covered- By Product and By Formulation Type
• Regions Covered- North America
• Competitive Landscape- Colorcon Inc., Merck KGaA, Colorcon Inc., Innophos Holdings, Inc., Lubrizol Corp., and Archer Daniels Midland Co. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North American Pharmaceutical Excipient Market- Segmentation

By Products

• Solubilizers & Surfactants/Emulsifiers
• Polyols
• Carbohydrates
• Specialty Excipients

By Formulations

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Formulations

North American Pharmaceutical Excipient Market– Segment by Region 

• US
• Canada